As Big Pharma races to create a vaccine for COVID-19, they’re susceptible to data breaches that could compromise intellectual property. A recent FiercePharma article discussed a recent event that led to the shutting down of multiple plants to contain the issue. As a preventative measure, Indian generics manufacturer Dr. Reddy’s Laboratories isolated all data center services after they detected a breach. The company has shut down “key” plants in the U.S., U.K., Brazil, India, and Russia. Dr. Reddy’s noted that they do not anticipate any major disruptions to operations due to the incident.
Dr. Reddy’s Shuts Down Plants Amid Potential Cyberattack
The Indian drugmaker detected a potential breach, and proactively shut down plants.
Oct 29, 2020